Jasper Ridge Partners, L.P. Gilead Sciences, Inc. Transaction History

Jasper Ridge Partners, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $17,504 - $19,994	-294 Reduced 1.92%	15,000 $925,000
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $18,660 - $20,388	294 Added 1.96%	15,294 $1.05 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $924,300 - $1.02 Million	15,000 New	15,000 $975,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Jasper Ridge Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Jasper Ridge Partners, L.P. with notifications on news.